H Yatsuhashi Selected Research

H Yatsuhashi Research Topics

5	Infections 01/2018 - 05/2000
3	Rheumatoid Arthritis 01/2008 - 09/2004
2	Chronic Hepatitis C 01/2018 - 05/2000
2	Liver Diseases (Liver Disease) 04/2014 - 01/2008
1	Hepatitis 01/2018
1	Hepatitis B 12/2015
1	Chronic Hepatitis B 12/2015
1	Coinfection 04/2014
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2008
1	Autoimmune Diseases (Autoimmune Disease) 01/2008
1	Autoimmune Hepatitis 01/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2000
1	Neoplasms (Cancer) 02/2000
1	Hepatocellular Carcinoma (Hepatoma) 02/2000

1	InterferonsIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	HLA-DPB1 antigen (HLA DPB1)IBA 12/2015
1	HLA-DP Antigens (HLA-DP)IBA 12/2015
1	Peptides (Polypeptides)IBA 12/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2015
1	AntigensIBA 12/2015
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2014
1	Serum AlbuminIBA 04/2014
1	AntibodiesIBA 01/2008
1	Anti-Citrullinated Protein AntibodiesIBA 01/2008
1	cyclic citrullinated peptideIBA 01/2008
1	Rheumatoid FactorIBA 01/2008
1	CytokinesIBA 04/2005
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 04/2005
1	AA amyloidosisIBA 04/2005
1	Leflunomide (Arava)FDA LinkGeneric 09/2004
1	azasteneIBA 09/2004
1	Immunomodulating AgentsIBA 09/2004
1	Matrix Metalloproteinases (MMPs)IBA 09/2004
1	RNA (Ribonucleic Acid)IBA 05/2000
1	antineoplaston A10 (A 10)IBA 05/2000
1	Capsules (Microcapsules)IBA 02/2000
1	acarboxyprothrombin (PIVKA)IBA 02/2000
1	Ethanol (Ethyl Alcohol)IBA 02/2000

2	Therapeutics 01/2018 - 04/2014
1	Aftercare (After-Treatment) 01/2018
1	Blood Transfusion (Blood Transfusions) 07/2008